CARLSBAD, Calif.--(BUSINESS WIRE)--To extend the benefits of genomic testing research for reproductive health labs, Thermo Fisher Scientific today launched two new next-generation sequencing-based ...
Biodesix recently validated Thermo Fisher’s tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer LOUISVILLE, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Biodesix, ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most undervalued large cap stocks to buy according to analysts. On July 3, Thermo Fisher Scientific announced that its Oncomine Dx Express Test, ...
Comprehensive portfolio—from women’s health to allergy, autoimmune and oncology testing—advances laboratory processes through the ability to provide earlier and more efficient detection and diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results